Private radiotherapy - Doctor with human Colon anatomy model

How Is Radiotherapy Used To Treat Colorectal Cancer?

Some kinds of cancer are less prevalent than they used to be. Reduced smoking rates have cut lung cancer rates, while awareness of the risks of sun exposure has reduced skin cancer frequency. But other cancers have increased.

Colorectal cancer is one such category, with instances of the disease on the rise across the globe.

The American Cancer Society predicted last year that there would be more than 154,000 diagnoses of the disease across the US, slightly up from its 2024 forecasts.

Forecasts of a rising incidence of gastrointestinal cancer in the US were backed up by a study by JAMA that showed not only were cases on the rise, but the increase was particularly focused on younger people.

Colorectal cancer in adults under 40 was up 3.4 per cent over the course of the decade, while pancreatic and gastric cancers were also up.

What Factors Increase The Risk Of Colorectal Cancer?

Speaking about these findings on the ABC Good Morning America show last year, the show’s medical correspondent, Dr Darien Sutton, listed several increased risk factors that were leading to higher incidences of gastrointestinal cancers:

  • Obesity
  • The consumption of highly processed foods
  • High consumption levels of sugary drinks
  • High levels of alcohol consumption
  • Increasingly sedentary lifestyles
  • Smoking

While the last of these may be less common than years ago, the others are not. However, it is clear that alongside not smoking, factors like more exercise, less alcohol and a healthy diet with more fibre and less red meat reduce risk, points Dr Sutton emphasised.

How is the Age Profile Of Colorectal Cancer Patients Changing?

American Cancer Society figures for 2025 highlighted just how skewed the increase was towards younger patients in the US.

The annual increase in colorectal cancer rates between 2012 and 2021 was 2.4 per cent in those aged under 50, but just 0.4 per cent for those in the 50-64 age range.

A key point to note was that the trends seen in the US echoed those around the world, where similar causal factors have been at play.

For example, an international study published in The Lancet in early 2025 highlighted the rising colorectal cancer incidence among younger adults in high-income Western countries.

However, while colorectal cancer is a rising problem around the world, especially in more affluent countries where lifestyles are more sedentary and the consumption of potentially harmful foods and beverages like red meat and sugary drinks is higher, there is good news.

While delivering its prediction of rising case numbers in 2025, the American Cancer Society noted that since the 1970s, patient outcomes for those with these forms of cancer had been steadily improving, partly thanks to more screening and lifestyle changes.

However, we may also consider just how radiotherapy has played a role in improved outcomes by noting how it can help to treat colorectal cancers and why treatments are now more effective than in the past.

On the one hand, the basics of radiotherapy remain the same as ever: The radiation disrupts the DNA of cancer cells, which breaks them down and prevents them from replicating. However, improvements in technology and scanning have made this process more precise.

How Is Radiotherapy Given For Colorectal Cancer?

Radiotherapy is usually delivered as external beam radiotherapy; specialised internal/contact techniques may be used in selected cases.

External beam therapy is given via a machine such as a LINAC machine, with the patient lying prone while the beams of radiation penetrate the skin to target the cancerous area.

This is often delivered in the form of intensity-modulated radiotherapy, which varies the strength of the beams of radiation to concentrate the higher doses on the cancer cells, while limiting the radiation exposure for the surrounding healthy tissue.

Brachytherapy involves a radioactive substance being placed inside the body, in this case, the colorectal area, to deliver the radiation. Two types can be used:

  • High dose rate brachytherapy, which is often given after external therapy
  • Low-energy contact brachytherapy, sometimes known as Papillon treatment, which is used as an alternative to surgery for cases of rectal cancer that have been detected very early

Any course of radiotherapy will come with side effects, although a benefit of intensity-modulated radiotherapy is that it reduces these because it limits the exposure in healthy tissue.

Nonetheless, some side effects will be common, such as

  • Fatigue
  • Hair loss
  • Nausea

Usually, these are temporary effects that wear off after treatment ends and younger patients will be better able to withstand the rigours of such treatment.

The best news about radiotherapy treatment for colorectal cancer is that, if detected early enough, this is a form of cancer that may often be removed entirely with a full recovery for patients.

Learn more about our advanced radiotherapy treatments for colorectal cancers on the Amethyst Group website.

Radiotherapy treatment - first linear accelerator technology IMRT

What Does LINAC-Based Radiotherapy Treatment Involve?

If you have been diagnosed with cancer and need radiotherapy treatment, there are various kinds you may receive, including internal and external radiotherapy and, in the latter case, different means of delivering it.

Depending on the type of radiotherapy you receive, you may become very familiar with a linear accelerator (LINAC) machine.

To understand what this is and what is involved, let us first consider the different kinds of radiotherapy:

  • Internal radiotherapy involves the injection of a radioactive substance into the body or your blood stream, enabling it to migrate to the location where it can deliver the radiation needed to disrupt the DNA of cancer cells
  • External beam radiotherapy involves beams of invisible radiation being directed to the body, aimed at the area or areas where the cancer resides
  • Stereotactic radiotherapy involves the use of precise beams of more intense radiation aimed at very specific locations, usually where the cancer is in or adjacent to sensitive organs like the brain. This sometimes involves a Gamma Knife instead of a LINAC machine.
  • Intensity-Modulated Radiation therapy is a form of radiotherapy delivered through a LINAC machine. It uses modulated beams shaped to the tumour and for different clinical scenarios than stereotactic treatments.

What Exactly Are LINAC Machines?

LINAC machines are large and complex devices that work by using a heated filament to effectively boil off electrons, which an accelerator then directs through further pieces of high-tech equipment, but the ultimate principle is simple.

These machines have been in use for decades. The concept was first proposed by physicist Gustav Ising in 1924, with the idea being modified. However, it wasn’t until 1953 that the first one, located in London, was used to treat patients.

What Cancers Do LINAC Machines Help To Treat?

Many primary cancers are commonly treated using a LINAC machine. These include:

  • Head and neck cancer
  • Brain and spine cancer
  • Breast cancer
  • Lung cancer
  • Prostate cancer
  • Blood cancer
  • Cancers of the reproductive systems, such as the womb, cervix or prostate
  • Cancers of the digestive system, such as the stomach, pancreas and liver
  • Colon and rectal cancers
  • Bladder cancer

In addition to these, it can also be used to treat metastatic (secondary) cancer that has spread from its original area to other parts of the body.

How Many Cancer Patients Are Treated With LINAC Machines?

This is a very wide range of cancers and highlights not just how broad a range of conditions the LINAC machine is equipped to treat, but also highlights how likely it is that any given cancer patient will, if prescribed radiotherapy, be given treatment in this machine. Over half of all cancer patients will have experienced this.

The experience of treatment in a LINAC machine will, at least the first time, be a novel one. The patient lies on a table, which is designed to be comfortable to recline on, before they slide backwards into the machine and lie still while the course of radiotherapy is delivered.

For some, this does bring the challenge of claustrophobia, although the patient will be able to stay calm as they can listen to soothing music. It is also possible to communicate with staff outside using an intercom.

What Is The Experience Of Radiotherapy Delivered By A LINAC Machine?

The session will last between ten to 30 minutes, depending on the cancer being treated, what stage you are at in the treatment course and individual factors.

While LINAC machines are used very widely, we will still ensure your treatment using one will be tailored specifically to your needs.

As with any radiotherapy treatment, you will be likely to experience some side effects due to the radiation, although the precision of the treatment will limit the exposure to healthy tissue. These commonly include:

  • Fatigue
  • Skin Soreness
  • Nausea
  • Hair loss

Most side effects are temporary and will ease once your course of treatment ends. For example, if you have lost your hair, you will find that it soon starts to grow back again.

If you undergo radiotherapy treatment with us involving a LINAC machine, you can be assured that you will receive tailored personal treatment and excellent aftercare, as well as being kept informed of how everything is progressing throughout the process.

Learn more about our advanced radiotherapy treatments for different cancers on the Amethyst Group website.

Stereotactic Radiosurgery - Stereotactic frame in hands of doctor

Why Is Stereotactic Radiosurgery Better For Prostate Cancer?

Prostate cancer is one of the most common forms of cancer to specifically affect men. According to the latest data, it accounts for just over 12 per cent of cancer cases in the European Economic Area and particularly affects men over the age of 45.

In addition, some ethnic groups are particularly prone to the disease, with black men at the highest risk. However, no racial group can be classed as ‘low risk’. The disease is curable, provided it is diagnosed at an early stage.

The fact that prostate cancer is so common does mean it has attracted a lot of attention, time and money for research into the disease and its treatments. This means that if you are a sufferer, you may have more treatment options open to you than you might be aware of.

If you are not happy with your current or proposed treatment, you may be keen on alternatives, not least if that means choosing radiotherapy over physical surgery. While surgery seeks to remove tumours and cancerous tissue, radiotherapy uses radiation to disrupt the DNA of cancer cells, destroying them and preventing cell replication.

What Is Involved In Prostate Cancer Surgery?

Going under the knife to have a tumour or even the whole prostate removed is a recognised and well-established treatment and it can be very effective. However, it has several potential downsides:

  • Urinary dysfunction, including incontinence
  • Negative changes to the experience of orgasm in sex
  • Loss of fertility
  • Erectile dysfunction
  • Lymphedema, a painful swelling in the legs or around the genitals

Such consequences mean that whatever the surgery achieves for the overall patient prognosis, there can be a significant deterioration in quality of life.

This alone might make radiotherapy sound like an alternative worth considering. But this will only be useful if it can be shown to be at least as effective in achieving its primary purpose of tackling the cancer itself.

What Are The Side Effects Of Radiotherapy For Prostate Cancer?

Moreover, radiotherapy for prostate cancer is also not without its possible side effects and long-term issues. These include:

  • Fatigue (short-term)
  • Issues with urinary, bowel and ejaculatory function (both short and long-term)
  • Infertility (long-term)
  • Erectile dysfunction (long-term)

There is more than one kind of radiotherapy, however, which means there are multiple options for using it to treat prostate cancer. Finding the best option for each patient is important for achieving the best possible outcomes.

What Research Supports Stereotactic Body Radiotherapy For Prostate Cancer?

An increasing body of research evidence is available to show that stereotactic body radiotherapy may be an effective and increasingly preferred option to deliver radiotherapy treatment to prostate cancer sufferers.

The latest study to show this comes from a Phase III trial held by University Hospitals Coventry and Warwickshire NHS Trust in the UK.

It carried out a study that compared the outcomes from a cohort of men who had five days of daily high-dosage stereotactic treatment to those of another group who underwent more standard radiotherapy treatment consisting of 20 sessions over four weeks.

The key finding of the trial was that the stereotactic radiotherapy produced results that were just as positive on average as those delivered by the longer courses of radiotherapy.

Consultant clinical oncologist at the trust, Andrew Chan, called the findings “a pivotal, practice-changing result”, as it meant that “for this highly prevalent cancer we are able to reduce radiotherapy treatment to only a quarter of the current standard – from 20 days to five days – with the same clinical benefits.”

This approach can have some great advantages for patients. Firstly, it is more practical as you only need to spare a few days to get it done, rather than a month.

Considering that the side-effects of radiotherapy can make you feel tired and unwell, this means you spend less time suffering and get the side-effects out of the way sooner.

What Are The Main Benefits Of Stereotactic Body Radiotherapy?

For selected patients with localised prostate cancer, stereotactic body radiotherapy is also likely to produce fewer side effects precisely because it is designed to focus the radiation on very precise areas, which means it not only blasts the cancerous tissue with higher doses of radiation, but greatly reduces the radiation exposure for adjacent, healthy tissue.

The term stereotactic radiosurgery was coined in the 1960s by Lars Leksell, the Swedish neuroscientist who invented the Gamma Knife, a device commonly used in tackling brain tumours.

The brain is a prime example of an organ in which exposure of healthy tissue to radiation needs to be minimised, but this benefit can also apply to other parts of the body.

Stereotactic body radiotherapy is one option that may be considered for eligible patients with prostate cancer, following assessment by a specialist clinical team

Learn more about our advanced radiotherapy treatments for prostate cancer on the Amethyst Group website.

Radiotherapy treatment - Female untangles her hair with a comb

How Can The Side Effects Of Radiotherapy Be Minimised?

Radiotherapy can be extremely effective against all kinds of cancer, using radiation to disrupt the DNA of cancer cells and prevent them from dividing and multiplying. It can shrink tumours, extend life, and, in many cases, eliminate cancer.

However, like many medical interventions, radiotherapy treatment does come with side effects. These can be varied, but the most common effects include:

  • Fatigue
  • Difficulties with eating and drinking
  • Nausea
  • Sore and discoloured skin
  • Hair loss
  • Loss of fertility (if radiotherapy occurs in the pelvic area or around the pituitary gland at the base of the brain)

This is not an exhaustive list, but it provides a clear picture: Radiotherapy can bring some unpleasant side effects that need to be handled and managed.

However, as radiotherapy has been used since the turn of the 20th century, these side-effects have become well understood and although they cannot be avoided, there are various ways in which they can be minimised in many cases, making the process much more manageable for patients.

What Activities Can You Still Do While Undergoing Radiotherapy?

For example, you might know people who have had cancer yet managed to do some very active things while undergoing treatment. An example of this that Alastair Welford, a 67-year-old from Warwickshire who recently began a 400-mile cycling challenge to raise money for a cancer charity, all while receiving radiotherapy for prostate cancer,

Mr Welford has not been free of side effects, but evidently they have not been so serious as to prevent him from undertaking a challenge that might be beyond many people in better health and of much younger age.

In his case, the treatment being given is MRI-guided radiotherapy. You may be familiar with MRI scans, which can be used to provide clear internal images of the body so medics can establish what is happening in a particular area without the need for an exploratory operation.

The benefit of using an MRI in cancer treatment is that it can help to locate precisely where a tumour or cluster of cancer cells is situated, as well as the size of the area. Modern use of MRI enables 3D imaging, which means that this can then be used to ensure the radiation applied in radiotherapy is directed with greater precision.

How Has More Precise Radiotherapy Been Made Possible?

Achieving increased accuracy in radiotherapy has been a key area of enhancement in the treatment. The more radiation can be directed very precisely at a cancer, the greater the medical effects in shrinking tumours and disrupting cancer cells. At the same time, the less radiation that gets into the surrounding tissue, the milder the side effects.

Indeed, the most accurately directed radiotherapy can require fewer sessions of treatment to have the necessary effects, because it is delivered more efficiently. This means reduced appointments and is therefore more practical for patients.

Radiotherapy can be delivered in different ways and for a condition like prostate cancer, external beam radiotherapy is used, directing the beams with precision at the affected area.

Among the innovations that have made possible more precise and intensified delivery of radiation is stereotactic radiosurgery. The term was invented in the late 1960s by Swedish neuroscientist Lars Leksell.

He invented the term as he introduced his defining invention to the world: the Gamma Knife. This device, despite its name, was anything but a knife, for it made non-invasive neurosurgery possible for the first time, as well as more precise radiotherapy.

The Gamma Knife is designed precisely for cases where the radiation has to be directed at very precise points, such as small tumours, but its original purpose was to deal with neurosurgery and that involves minimising the amount of brain tissue that is exposed to radiation.

How Can Stereotactic Radiotherapy Benefit Prostate Cancer Patients?

However, stereotactic radiosurgery can also be applied to other parts of the anatomy on the same principle; that it is beneficial to the patient to minimise the exposure of radiation for sensitive organs that lie close to the site of the cancer.

This can apply to prostate cancer, as that can reduce exposure to nearby pelvic organs. As well as issues of fertility, notable side effects can include incontinence. Prostate cancer patients may still suffer from these (especially infertility), but the exposure to radiation of other organs nearby will be reduced and the wider impact minimised.

Of course, not every patient will be able to jump on a bike and ride 400 miles over the course of a few days between treatment sessions. But equally, stereotactic radiosurgery is delivered in a way that will bring a lot less disruption to normal life than other forms of radiotherapy.

This will mean that it takes less time out of your schedule, while also enabling you to do more of your normal activities.

Learn more about our advanced radiotherapy treatments for different cancers on the Amethyst Group website.

private radiotherapy - christmas and new year medical banner

How To Enjoy The Festive Season While Receiving Radiotherapy

Christmas is a time of togetherness, joy and merriment, as friends, family and loved ones come together to celebrate, share moments and memories and look towards the promise of a new year.

However, this spirit of the season can also be a challenge for people undergoing radiotherapy, chemotherapy and other forms of cancer care.

Festive celebrations are often a further disruption to your schedule beyond the radiotherapy sessions, with the inadvertent pressure that can come from family gatherings.

You are not alone at Christmas, and people are here to help with whatever you need. But here are some tips and tricks to help cope with both the practical and emotional complexities of the season.

Why Is Christmas Difficult Whilst Being Treated For Cancer?

For some people undergoing cancer treatment, Christmas is a welcome break from the routine, provides a chance to rest and recover, whilst also celebrating their progress with the people who love them most.

However, at the same time, the very hope and magic that make Christmas what it is can also be more difficult. Whilst some people enjoy the occasion, others may feel more apprehensive about it:

  • You might feel a subconscious pressure to avoid talking about negative feelings, anxieties or uncertainties so as not to upset other people.
  • You could feel lonely or isolated at a time when healthcare and support tend to operate a more limited emergency service.
  • You may be feeling additional fatigue or the effects of symptoms due to a more intense or stressful schedule than usual.

If you feel anything like this, know that it is natural, you are not alone, and with some planning and support, these challenges can be managed to ensure you have an enjoyable Christmas.

How Should You Prepare For Christmas Celebrations?

Preparation is a key part of Christmas, and if you are undergoing cancer treatments, there is an additional set of preparations you will need to make in order to enjoy yourself the most and give yourself the most peace of mind, whether you are hosting guests, going somewhere for the holidays or are taking some time for yourself.

Get Emergency Contact Details

Many clinics will have reduced hours or will close entirely over the festive period, so it is important to know your options.

Your cancer team and particularly your main points of contact within that team will likely talk to you about what to expect during the break, when your next appointment is and what you should do if you feel unwell.

Make sure to prompt them for contact details so you know what to expect ahead of time.

Check Your Prescriptions

If you are taking medications ahead of time or have medical equipment you need to use as part of your treatment, make sure you have enough to get you through the entire festive season. Get in touch with your doctor to make sure you have any prescriptions.

As well as this, ask your cancer team if you need any additional medications to help with symptoms over the holiday, such as nausea or fatigue, and jot down a list of medications you are likely to take.

Let Your Hosts Know Your Needs

If you are seeing family or friends, they will want to do everything they can to make your time more comfortable, so let them know what you need when it comes to dietary requirements, if you need a quiet room to get away or if you need to leave early.

How Can You Manage Symptoms During Christmas Festivities?

Cancer treatment can have better or worse days, and your cancer team will do what they can to ensure you are comfortable leading up to any Christmas gatherings. However, here are some steps you can take to help relieve common symptoms specific to festive parties.

Only Eat What You Feel Comfortable Eating

Let your host know ahead of time if your food needs to be a particular consistency or if you need a smaller portion. Christmas foods are often rich, filling and flavourful, and this can be overpowering if your mouth or stomach is more sensitive.

If you take anti-sickness tablets, check to see if you need to adjust your dosing schedule.

Set Reminders To Take Your Medicines

If you take pain medication, it is possible to be distracted or forget to take it due to the events of the day, so set reminders on your phone to make sure you take the medications you need at the right time.

Cushion Yourself

If you are sensitive to physical contact, putting a cushion on your lap can help soften any young children or pets giving overeager hugs.

Take Rests Whenever You Need Them

Most Christmas parties will have a quiet room or a place where you can escape the noise and the conversations. Let people know whenever you need to take a break, sit down or even have a lie down during the day.

Private chemotherapy treatment - Woman Undergoing Chemotherapy

Could New Chemotherapy Treatments Offer Better AML Options?

Leukaemia comes in several different forms and the available treatments vary. For those with acute myeloid leukaemia (AML), there are different chemotherapy options and research has indicated some of them may be much more favourable for older patients.

If you or a family member has leukaemia, the diagnosis can be confusing. The term relates to blood cancer, but there are several different forms of the disease.

The most common types include:

  • Chronic lymphatic leukaemia
  • Acute lymphatic leukaemia
  • Chronic myeloid leukaemia
  • Acute myeloid leukaemia (AML)

The chief distinction in types is between chronic leukaemia, where the cancer is slow-growing, and acute, where it progresses quickly.

In the latter case, the disease is manifested in the bone marrow, where non-functional blood cells build up in the marrow. This absence of function impedes the ability of the marrow to produce sufficient healthy blood cells.

For a patient diagnosed with AML, this means there is an excessive production of abnormal white blood cells, which reduces the production of the normal type responsible for essential immune system functions.

How Is Acute Myeloid Leukemia Treated?

Treatments for AML can include chemotherapy as well as radiotherapy, stem cell treatments and targeted therapy.

As with any cancer, every patient’s circumstances are different, based on various demographic, background health, genetic and other factors, as well as how early the diagnosis takes place.

Many patients might find that this is not their experience of treatment; however. Some may encounter a formulaic, one-size-fits-all approach.

This might work well for some patients but much less so for others. That is why many patients could benefit greatly from personalised private chemotherapy treatment.

In the case of AML, chemotherapy usually starts very soon after diagnosis and can involve an extended hospital stay. Combinations of different therapies are given, each aiming to target cancer cells.

Because this can take weeks and the side effects can be significant for patients, the preferred treatment is one that is as gentle as possible, especially for older, frailer patients who may not be in sufficiently robust condition to handle some treatments.

This must be balanced with finding the most effective treatments that have the greatest impact on the cancer to produce the best longer-term patient outcomes.

Are There Any New Chemotherapy Developments For Acute Myeloid Leukemia?

Encouraging news on this front has emerged from new research in the United States. The University of Miami Miller School of Medicine has published a study with the positive conclusion that the newest chemotherapy drugs offer older adults the dual benefits of being gentler with less pronounced side effects, as well as significantly better patient outcomes.

Although AML can affect patients of any age, the prevalence is far higher in people over the age of 60, which means a combination of age and the emergence of other health conditions in later life can limit the tolerance patients have of intensive therapies.

This has seen the old, standard approach of newly diagnosed patients undergoing intensive chemotherapy (and sometimes other treatments) early on in an attempt to achieve remission with gentler, low-dose therapies that have proved more effective in terms of final outcomes (extended life and outright cures), as well as being more tolerable.

Summarising these findings, which were published in the journal Blood Advances, study leader Mikkael Sekeres said: “The landscape of AML treatment has changed dramatically with more effective therapies,” adding that recent research has led to the US Food and Drug Administration approving three new acute leukaemia drugs in the past two years.

However, he observed, incorporating new drugs into patient treatments is not a quick process.

Even so, the fact that new drugs with better all-round outcomes for older patients in particular have emerged provides good reasons for increased optimism about the ability of patients to handle the treatment and the outcomes.

How Can Personalised Therapy Help AML Patients?

If you have AML, the chemotherapy you may have had so far might have followed the more standard path and might have turned out to be gruelling. It may not necessarily be effective either, as it is in the nature of such treatments that some drugs work better on some patients than others.

This is why tailored private chemotherapy treatment may provide solutions that other treatments you have received up until now have not. Our approach is always centred on the patient as an individual and the development of new chemotherapy drugs provides more opportunities to offer something new and different.

If you come to us for cutting-edge chemotherapy treatment for AML or other forms of leukaemia, you can be sure we will provide personalised care based on the best available options, which will take all of your circumstances into account.

Learn more about our advanced chemotherapy treatments for leukaemia on the Amethyst Group website.

Radiotherapy centre - Digital composite of highlighted red pancreas

How Can Radiotherapy Help Treat Pancreatic Cancer?

There are many different forms of cancer, but the majority of cancer cases are accounted for by a handful of very common forms of the disease. These include breast, prostate, lung and bowel cancer.

Pancreatic cancer is much less common although still a significant health issue in Europe, ranking as the seventh most commonly diagnosed cancer and the third or fourth leading cause of cancer-related death, after lung and colorectal cancers.

Each year, approximately 100,000 new cases are diagnosed across the EU, with a similar number of deaths. Incidence and mortality continue to rise, driven largely by ageing populations, with particularly high rates observed in Central and Eastern Europe (e.g. Latvia and Hungary) and Western Europe (e.g. France and Germany).

These numbers may be lower than for other cancers, but they are rising and expected to rise further. 

Research has projected that, globally, the rate of pancreatic cancer incidence will be more than 31 per cent higher in 2040 than in 1990, with women at greater risk than men. In the US, the present lifetime risk is one in 60 for men and one in 56 for women.

Our radiotherapy centre does not just offer treatments for the most common forms of cancer. Indeed, we can and do treat less common forms of the disease than pancreatic cancer.

Pancreatic cancer tends to have a comparatively poorer prognosis for patients than other cancers. The main reason for this is that diagnosis tends to occur at a late stage; as with any type of cancer, the earlier the diagnosis, the more that various treatments can achieve in combating it.

What Are The Different Stages Of Pancreatic Cancer?

There are different kinds of pancreatic cancer, the majority of which start at the head of the pancreas.

Whichever type a patient is diagnosed with, there are five stages of the cancer, which indicate how far the disease has progressed and will shape the type of treatment possible, including the role that radiotherapy can play.

These stages are:

  • Stage Zero (carcinoma in situ), where the cancer is only at the top layer of the cells and has not grown into the pancreas. Diagnosis this early is rare.
  • Stage 1, where the cancer is in the pancreas but has not spread to the lymph nodes or elsewhere in the body.
  • Stage 2, where the cancer has started to grow into surrounding tissue and may be in the lymph nodes
  • Stage 3, known as locally advanced cancer, where the disease has spread to the lymph nodes and local blood vessels, but not other organs
  • Stage 4, where the cancer has metastasised, which means it is now present elsewhere in the body and is classed as secondary cancer

A key distinction is that surgery is usually possible at stages one and two, but not three or four.

How Is Radiotherapy Used In Treating Pancreatic Cancer?

The role of radiotherapy in treating pancreatic cancer can vary. In some cases, it is used alone, whereas in other cases it can be combined with chemotherapy. As with any radiotherapy treatment, the aim is to use radiation to damage the DNA of the tumour and cancer cells, targeting cells and shrinking the tumour.

The combined use of radiotherapy and chemotherapy is known as chemoradiotherapy. This can be used to shrink a tumour that is slightly too large to be removed by surgery. Once it has shrunk sufficiently, surgery can be possible.

Radiotherapy can also be used for late-stage pancreatic cancer as a form of palliative care, providing some significant relief from pain.

Patients undergoing radiotherapy will usually receive it through external beam therapy, which means the patient will lie down while a linear accelerator (Linac) machine directs radiation at the affected area.

What Is Stereotactic Radiotherapy And Why Is It Sometimes Used?

In some instances, a higher level of precision is necessary. This is known as stereotactic radiotherapy and will involve highly focused radiation beams being aimed at a small, specific area.

This will be done with the aim of minimising exposure for surrounding tissue and is commonly used to treat various cancers in which tumours are located very close to vital organs.

The sessions will be short and close together, whereas Linac sessions tend to be longer and take place over a greater period of time.

As with any course of radiotherapy, there may be side effects. These can include tiredness, digestive symptoms, sore skin, hair loss and loss of sexual function. However, these symptoms are usually temporary; for example, after a course of radiotherapy ends, lost hair can soon start to grow back.

Our approach to treatment is always to ensure that every individual gets the best possible course tailored to their specific needs, whatever form or stage of pancreatic cancer may be present.

This will take into account all the circumstances of the patient and will always be done with clear communication and explanations about your treatment and care.

Learn more about our advanced radiotherapy treatments for pancreatic cancer on the Amethyst Group website.

Radiotherapy Treatment - Hands joined in circle holding breast cancer struggle symbol

How Can Radiotherapy Be Used To Treat Breast Cancer?

Breast cancer is one of the most common forms of cancer affecting women and, like so many other cancers, the prospects for the patient depend heavily on early diagnosis and treatment.

Radiotherapy treatment can play a major role, but for certain risk groups it may not be needed following a mastectomy. This article explains what has changed and what has not.

Breast cancer most commonly affects women over the age of 50, but it can affect patients below this age. Men can develop breast cancer too, although this is very rare.

The first signs are usually the discovery of an unusual lump in a breast. Screening and other tests can help to confirm if the lump is benign or cancerous.

How Is Breast Cancer Treated?

Once a diagnosis takes place, there are several treatment options. These are:

  • Mastectomy (surgical removal of the whole breast)
  • Breast conserving surgery (when the cancerous tissue is removed along with surrounding breast tissue, but most of the breast remains in place)
  • Chemotherapy
  • Hormonal therapy
  • Radiotherapy

These are often used in combination. For example, adjuvant chemotherapy and hormonal therapy may be used before surgery.

In stages 1-3 of cancer, Radiotherapy can be used after surgery, both after breast-conserving surgery and a mastectomy.

However, you may rightly query whether radiotherapy will be used after a mastectomy, as recent research has indicated that this may no longer be necessary. This was the finding of an international study carried out by the University of Edinburgh in the UK and published in the New England Journal of Medicine.

What Did The Edinburgh Study Reveal About Post-Mastectomy Radiotherapy?

Normally, radiotherapy is used after various kinds of cancer surgery to target any remaining cancer cells that remain following surgery. This can apply to various cancers found in different parts of the body.

However, the Edinburgh study found that when surgery is used in conjunction with anti-cancer drugs, radiotherapy can safely be skipped with no adverse consequences for patients.

A study of patients from 17 countries revealed that the ten-year survival rates were not significantly different between those who had undergone post-operative radiotherapy and those who had not.

Specifically, there was no difference between the two groups in either the recurrence of the disease or metastasis (where secondary cancer takes place as it spreads from the original site to other parts of the body).

When Might Radiotherapy Still Be Used For Breast Cancer?

However, while this study indicates that radiotherapy may not be useful in this particular instance, when a full mastectomy has been carried out early after diagnosis, there are other instances when radiotherapy may still be an important and effective treatment.

Firstly, the study only applied to the situation for patients who had undergone a mastectomy, so it does not provide any basis to change established practice for patients who have had breast-conserving surgery.

Secondly, radiotherapy can be particularly important in treating secondary cancer that has arisen from breast cancer.

Two key factors can influence the likelihood of this happening: the first being later diagnosis, which gives the cancer a greater chance to spread before treatment, while the second depends on variations in oestrogen receptor status, which makes some patients more likely to experience metastasis than others.

Radiotherapy is not the only treatment you may have for secondary cancer, with others including chemotherapy and hormonal treatments, but it is commonly used.

This will be delivered as external beam therapy and locations where this is often used include the bones or the brain, these being two of the most common sites for secondary breast cancer to manifest.

What Are the Benefits Of Personalised Radiotherapy For Secondary Breast Cancer?

Benefits arising from such treatment include the relief of symptoms and the slowing down of cancer progression. Although secondary breast cancer is usually not curable, radiotherapy and systemic treatments can often control the disease and help people live well for longer.

If you come to our private radiotherapy centre, our work will involve devising the right treatment programme based on your circumstances. That may include post-op radiotherapy if you have had breast-conserving surgery for primary cancer, or radiotherapy for secondary cancer.

Each treatment programme is geared to the needs of the individual. This is partly because of variations in your medical situation, such as where any secondary cancer has spread to, your age, your overall medical health, as well as what has (or has not) worked well in any previous treatment you have had.

Beyond this, our aim is always to ensure every patient is treated as the individual they are, tailoring each and every aspect of care to their personal circumstances in order to provide the best possible patient outcomes.

Learn more about our advanced radiotherapy treatments for breast cancer and secondary cancers on the Amethyst Group website

Gamma knife - radiotherapy ultrasonic head

How Has Gamma Knife Treatment Developed Over The Years?

Radiotherapy has been around since the turn of the 20th century, but as our understanding of radiation has improved and the technology for deploying it has developed, so has the capacity to bring about better results for patients.

If you require radiotherapy, there are different kinds you may have depending on your condition. For some, the form used is stereotactic radiotherapy. This involves directing very precise beams of radiation at very small and specific areas, with the purpose of providing the maximum impact on a tumour while minimising exposure to surrounding tissue.

This form of radiotherapy is particularly valuable when the cancer is close to the most important organs, which include the brain. One of the devices through which it can be delivered is Gamma Knife.

What Is Gamma Radiation And Why Is It Used In Radiotherapy?

To understand what Gamma Knife does, it helps to know more about radiation. It comes in four types:

  • Alpha particles, which are seldom harmful and not usually useful in radiotherapy, as they cannot penetrate the skin or even objects like clothing or a sheet of paper.
  • Beta particles, which can only penetrate part of the way into your skin
  • Gamma radiation and X-rays. These can both penetrate the skin as they consist not of particles, but of rays, in the same way light waves or radio waves do.

In the case of X-rays, everyone will be familiar with their use in medical scanning. But gamma rays are more powerful and, apart from their ability to penetrate the body, have a major impact on whatever they encounter. Radiation can destroy cell DNA, which is useful in tackling tumours as it leads to cell death and therefore prevents tumours from growing.

The knowledge of the power of gamma rays led scientists to use them in radiotherapy. But Gamma Knife was a significant step forward.

Despite its name, it isn’t a knife in the normal surgical sense, as there is nothing invasive about its use. After all, it is the property of gamma radiation to penetrate the skin that makes it effective.

Who Invented Gamma Knife?

The device was first devised by the Swedish neurosurgeon Lars Leksell in the 1960s. By 1968, he had the device up and working and he was using it at the Karolinska Hospital in Stockholm.

Using a gamma radiation source and directing the beams with great precision, Prof Leksell was soon using it both to treat brain tumours and also other neurological conditions.

Indeed, even epilepsy and nerve conditions like trigeminal neuralgia can be treated as Gamma Knife can target specific nerve pathways with highly focused radiation, disrupting pain signals without the need for open surgery..

As a result, the lives of many cancer patients have been saved or at least extended, while people suffering from other conditions have enjoyed much relief from them, thanks to Gamma Knife.

A second version of the device emerged in 1974 and its use soon spread beyond Stockholm. The first Gamma Knife to be used in the UK arrived in 1985. Four decades on, it is much more widely used and we have extensive experience of using it for different treatments.

We would be likely to use it if you have a brain tumour in a place that is difficult and/or dangerous to reach and cut out with surgery. However, it may also be used in combination with physical surgery, often being used after the removal of a tumour to prevent it from growing back.

What Other Equipment Is Used To Help Gamma Knife?

It might be expected that any invention from 1968 could be improved upon, but while the device itself has been enhanced to an extent, it is still fundamentally the same thing as it was. However, there are other pieces of technology that can help to make the gamma knife even more effective.

Before and even during radiotherapy, MRI, CT and PET scans are used to help direct the beams of radiation with ever greater precision. Among the benefits of the most modern technology is the ability to do this in 3D, which is especially useful when the beams of gamma radiation are directed from different angles to maximise the impact on a tumour.

If you need stereotactic radiotherapy, you may soon be encountering the Gamma Knife. Like any form of radiotherapy, it will bring some side effects, but the precision of the device and the fact that a course of treatment can be delivered in fewer sessions than other forms of radiotherapy will help to minimise this, as well as ensuring it is over sooner.

A growing number of people have benefited from the use of Gamma Knife over the years, including many of our patients.

Learn more about our advanced Gamma Knife treatments on the Amethyst Group website.

amethyst

Amethyst-Stingray Alliance Featured By HBI

Investment platform Healthcare Business International (HBI) has published a news story on the new alliance between private oncology groups Amethyst Healthcare (with centres in seven countries across Europe) and Stingray (with a major presence in both France and Germany).

The integration was made possible thanks to the acquisition of Stingray by private equity firm Fremman Capital, with the new combined entity to operate 30 treatment centres across eight countries: the UK, France, Germany, Italy, Poland, Austria, Portugal and Romania. 

In all, 60 linear accelerators will be in use, delivering approximately 35,000 radiotherapy treatments each year. This makes the group Europe’s biggest private cancer care provider, with revenue of more than €200 million.

It will be led by Stingray CEO Ralph Hefti, although the Amethyst clinics will retain the Amethyst brand for the foreseeable future to support brand familiarity. However, a new brand may be established at some point.

Speaking to the news source, Mr Hefti said: “For me the concept of an integration implies that you lose something. I would see the intention here being a bit different: to add together two businesses which historically were already two of the three leading radiotherapy platforms in Europe in terms of size, financials, KPIs etc. 

“But what is important is really the combination of the two different operating models. Amethyst is very much a brand to patients whereas Stingray is a value proposition to doctors and to institutions. 

“By combining the two, not only do we get the obvious benefits of size and potential for economies of scale, but we also combine the value proposition so that it is a platform that offers new opportunities to institutions, hospitals, doctors and medical professionals.”

He went on to say that the group now has over 1,000 oncology professionals on staff, making it the biggest team of cancer professionals in Europe – and perhaps even the world. 

This, Mr Hefti continued, will address what he described as the biggest bottleneck in healthcare services by becoming an attractive brand for those in the profession, tackling staff shortages head on.

Learn more about our advanced radiotherapy and neurosurgical treatments for different cancers on the Amethyst Group website.

Fremman buys Stingray to merge with Amethyst – PDF